XII Medical, Inc. raised $45 million in a Series B financing led by Omega Funds and Intuitive Ventures to advance their neuromodulation therapy for obstructive sleep apnea.
XII Medical, Inc. raised $45 million in a Series B financing led by Omega Funds and Intuitive Ventures to advance their neuromodulation therapy for obstructive sleep apnea.
08/21/24, 2:17 PM
Location
union cityMoney raised
$45 million
Round Type
series b
Investors
Undisclosed Strategic Investor, Jobs Ohio Growth Capital Fund, Aperture Venture Partners, Longview Ventures, Ajax Health, Cleveland Clinic, Intuitive Ventures, Omega Funds
XII Medical, Inc. announced the closing of a $45 million Series B equity financing to further product and clinical development of its innovative therapy for obstructive sleep apnea. The financing was led by Omega Funds and included participation from various existing and new investors.